TRCT
SRTA

Tower Research Capital (TRC)’s Strata Critical Medical Inc SRTA Stock Holding History

Tower Research Capital (TRC)’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Sell
2,929
-4,298
-59% -$20.7K ﹤0.01% 3802
2025
Q4 		$34.8K Buy
7,227
+2,258
+45% +$10.9K ﹤0.01% 2701
2025
Q3 		$25.1K Sell
4,969
-9,683
-66% -$42.8K ﹤0.01% 3094
2025
Q2 		$59K Buy
14,652
+5,808
+66% +$18.9K ﹤0.01% 2830
2025
Q1 		$24.1K Buy
8,844
+5,969
+208% +$21.4K ﹤0.01% 2793
2024
Q4 		$12.2K Sell
2,875
-1,486
-34% -$5.66K ﹤0.01% 3638
2024
Q3 		$12.8K Sell
4,361
-3,873
-47% -$12.3K ﹤0.01% 3557
2024
Q2 		$28.7K Buy
8,234
+5,640
+217% +$18.8K ﹤0.01% 3516
2024
Q1 		$7.39K Sell
2,594
-6,921
-73% -$21.4K ﹤0.01% 4211
2023
Q4 		$33.6K Buy
9,515
+332
+4% +$953 ﹤0.01% 3356
2023
Q3 		$23.8K Buy
9,183
+7,683
+512% +$27K ﹤0.01% 3216
2023
Q2 		$5.91K Sell
1,500
-4,842
-76% -$15.4K ﹤0.01% 4774
2023
Q1 		$21K Buy
6,342
+5,865
+1,230% +$23.9K ﹤0.01% 3372
2022
Q4 		$2K Sell
477
-3,582
-88% -$15.3K ﹤0.01% 5332
2022
Q3 		$16K Buy
4,059
+325
+9% +$1.67K ﹤0.01% 4108
2022
Q2 		$17K Buy
3,734
+2,259
+153% +$16.3K ﹤0.01% 3943
2022
Q1 		$13K Buy
1,475
+1,454
+6,924% +$10.2K ﹤0.01% 3958
2021
Q4 		$0 Sell
21
-485
-96% -$4.61K ﹤0.01% 6137
2021
Q3 		$5K Buy
+506
New +$4.42K ﹤0.01% 4828
2021
Q1 		– Sell
-6,834
Closed -$76K – 5401
2020
Q4 		$76K Buy
6,834
+3,986
+140% +$40.7K ﹤0.01% 2620
2020
Q3 		$28K Buy
2,848
+2,671
+1,509% +$27K ﹤0.01% 3747
2020
Q2 		$2K Buy
+177
New +$1.74K ﹤0.01% 4471

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s SRTA Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Strata Critical Medical Inc (SRTA) stake by 59% in Q1 2026, selling an estimated $20.7K and leaving 2,929 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

Tower Research Capital (TRC) first reported a position in SRTA in Q2 2020 and has held it in 22 quarters since. The position peaked at $76K in Q4 2020. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Tower Research Capital (TRC) held 2,929 shares of Strata Critical Medical Inc worth $12.2K as of Q1 2026.
  • Tower Research Capital (TRC) sold 4,298 Strata Critical Medical Inc shares in Q1 2026, an estimated $20.7K.
  • Strata Critical Medical Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3802 holding.
  • Tower Research Capital (TRC) first reported a position in Strata Critical Medical Inc in Q2 2020 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Strata Critical Medical Inc position peaked at $76K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.